Legal Representation
Attorney
Thomas Dietrich
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 22, 2026 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 22, 2026 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 22, 2026 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 7, 2026 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 7, 2026 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 7, 2026 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 12, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 25, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 24, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 7, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 7, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for peptide therapy for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Syringes sold filled with peptide preparations for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Pharmaceutical preparations for skin care; Therapeutic pharmaceutical for the treatment of aging, hormone imbalance, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment of aging-related conditions, hormone imbalances, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment and prevention of aging-related conditions; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; Synthetic peptides for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes
Class 044
Telemedicine services; Health care services for treating aging and loss of biological function through peptide therapy; Providing personalized healthcare and medical information in the nature of peptide therapy; Health care services, namely, peptide therapy; Health care consulting in the field of peptide therapy; Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
LABS